Suparma (SPMA) 주식 개요인도네시아에서 종이 및 관련 종이 제품을 제조 및 판매하는 기업입니다. 자세히 보기SPMA 펀더멘털 분석스노우플레이크 점수가치 평가4/6미래 성장0/6과거 실적4/6재무 건전성6/6배당0/6강점공정 가치 추정치보다 낮은 82.8% 에서 거래지난 1년간 수익이 8.2% 증가했습니다.위험 분석지난 5년간 매년 수익이 23.6% 감소했습니다.의미 있는 시가총액이 없습니다(IDR820B)모든 위험 점검 보기SPMA Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueRpCurrent PriceRp200.00107.1% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture03t2016201920222025202620282031Revenue Rp2.8tEarnings Rp105.2bAdvancedSet Fair ValueView all narrativesPT Suparma Tbk 경쟁사Pabrik Kertas Tjiwi KimiaSymbol: IDX:TKIMMarket cap: Rp20.9tIndah Kiat Pulp & PaperSymbol: IDX:INKPMarket cap: Rp43.8tGunawan Dianjaya SteelSymbol: IDX:GDSTMarket cap: Rp831.8bMadusari Murni IndahSymbol: IDX:MOLIMarket cap: Rp642.9b가격 이력 및 성과Suparma 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가Rp200.0052주 최고가Rp338.4652주 최저가Rp190.77베타0.591개월 변동-10.71%3개월 변동-10.71%1년 변동-2.26%3년 변동-41.44%5년 변동-25.42%IPO 이후 변동191.96%최근 뉴스 및 업데이트Reported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: Rp20.18 (vs Rp7.72 in 3Q 2023)Third quarter 2024 results: EPS: Rp20.18 (up from Rp7.72 in 3Q 2023). Revenue: Rp686.1b (up 5.5% from 3Q 2023). Net income: Rp65.9b (up 171% from 3Q 2023). Profit margin: 9.6% (up from 3.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.더 많은 업데이트 보기Recent updatesReported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: Rp20.18 (vs Rp7.72 in 3Q 2023)Third quarter 2024 results: EPS: Rp20.18 (up from Rp7.72 in 3Q 2023). Revenue: Rp686.1b (up 5.5% from 3Q 2023). Net income: Rp65.9b (up 171% from 3Q 2023). Profit margin: 9.6% (up from 3.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Reported Earnings • Jul 31Second quarter 2024 earnings released: EPS: Rp8.89 (vs Rp12.20 in 2Q 2023)Second quarter 2024 results: EPS: Rp8.89 (down from Rp12.20 in 2Q 2023). Revenue: Rp618.2b (up 2.5% from 2Q 2023). Net income: Rp26.4b (down 31% from 2Q 2023). Profit margin: 4.3% (down from 6.4% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.New Risk • Jul 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.6% net profit margin). Market cap is less than US$100m (Rp908.4b market cap, or US$55.4m).공시 • May 09PT Suparma Tbk, Annual General Meeting, Jun 14, 2024PT Suparma Tbk, Annual General Meeting, Jun 14, 2024. Location: Vasa Hotel Surabaya Jawa Timur IndonesiaReported Earnings • May 04First quarter 2024 earnings released: EPS: Rp7.00 (vs Rp25.65 in 1Q 2023)First quarter 2024 results: EPS: Rp7.00 (down from Rp25.65 in 1Q 2023). Revenue: Rp657.6b (down 5.9% from 1Q 2023). Net income: Rp22.6b (down 72% from 1Q 2023). Profit margin: 3.4% (down from 12% in 1Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 7% per year.New Risk • Apr 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.7% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.7% net profit margin). Market cap is less than US$100m (Rp1.09t market cap, or US$68.4m).Reported Earnings • Apr 03Full year 2023 earnings released: EPS: Rp57.00 (vs Rp107 in FY 2022)Full year 2023 results: EPS: Rp57.00 (down from Rp107 in FY 2022). Revenue: Rp2.66t (down 15% from FY 2022). Net income: Rp178.7b (down 47% from FY 2022). Profit margin: 6.7% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year.Valuation Update With 7 Day Price Move • Oct 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to Rp338, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 4x in the Forestry industry in Indonesia. Total returns to shareholders of 85% over the past three years.Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: Rp12.30 (vs Rp10.32 in 2Q 2022)Second quarter 2023 results: EPS: Rp12.30 (up from Rp10.32 in 2Q 2022). Revenue: Rp603.0b (down 23% from 2Q 2022). Net income: Rp38.5b (up 4.8% from 2Q 2022). Profit margin: 6.4% (up from 4.7% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth.공시 • May 19PT Suparma Tbk, Annual General Meeting, Jun 08, 2023PT Suparma Tbk, Annual General Meeting, Jun 08, 2023, at 03:00 Coordinated Universal Time. Location: Meeting Room of PT Suparma Tbk Jl. Mastrip No. 856 Surabaya Indonesia Agenda: To consider the approval on the company's annual report including the company's audited financial statements and the board of commissioners' Supervisory Duty Report for financial year ended on December 31, 2022; to consider to determine the use of the company's net profit for the financial year ended on December 31, 2022; to consider to appoint the Registered Public Accountant and/or Registered Public Accounting Firm that will Audit the company's financial statements for the financial year ended on December 31, 2023; and to transact such other business issues.Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Corporate Secretary & Independent Director Hendro Luhur is the most experienced director on the board, commencing their role in 1998. Independent Commissioner M. Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Nov 06Third quarter 2022 earnings released: EPS: Rp54.76 (vs Rp72.09 in 3Q 2021)Third quarter 2022 results: EPS: Rp54.76. Revenue: Rp814.9b (up 15% from 3Q 2021). Net income: Rp130.9b (up 12% from 3Q 2021). Profit margin: 16% (in line with 3Q 2021).Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp555, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 15x in the Forestry industry in Indonesia. Total returns to shareholders of 145% over the past three years.Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp755, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 19x in the Forestry industry in Indonesia. Total returns to shareholders of 266% over the past three years.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Commissioner Tan Juanto was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp815, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 325% over the past three years.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp685, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 247% over the past three years.Valuation Update With 7 Day Price Move • Nov 24Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp585, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 213% over the past three years.Reported Earnings • Nov 07Third quarter 2021 earnings released: EPS Rp79.47 (vs Rp7.85 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp710.0b (up 30% from 3Q 2020). Net income: Rp117.1b (up 435% from 3Q 2020). Profit margin: 17% (up from 4.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Nov 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to Rp422, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 131% over the past three years.Reported Earnings • Jul 30Second quarter 2021 earnings released: EPS Rp24.89 (vs Rp30.91 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: Rp616.9b (up 43% from 2Q 2020). Net income: Rp37.7b (down 56% from 2Q 2020). Profit margin: 6.1% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 27% per year.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp390, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 112% over the past three years.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp610, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 123% over the past three years.Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to Rp520, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 12x in the Forestry industry in Indonesia. Total returns to shareholders of 82% over the past three years.Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp370, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 24% over the past three years.Is New 90 Day High Low • Feb 26New 90-day high: Rp336The company is up 3.0% from its price of Rp326 on 27 November 2020. The Indonesian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 62% over the same period.Is New 90 Day High Low • Jan 28New 90-day low: Rp276The company is down 1.0% from its price of Rp280 on 27 October 2020. The Indonesian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 61% over the same period.Is New 90 Day High Low • Nov 11New 90-day high: Rp296The company is up 15% from its price of Rp258 on 13 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 1.0% over the same period.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of Rp118.1b, down 19% from the prior year. Total revenue was Rp2.18t over the last 12 months, down 15% from the prior year.주주 수익률SPMAID ForestryID 시장7D-4.8%-12.3%-7.4%1Y-2.3%21.0%-15.5%전체 주주 수익률 보기수익률 대 산업: SPMA은 지난 1년 동안 21%의 수익을 기록한 ID Forestry 산업보다 저조한 성과를 냈습니다.수익률 대 시장: SPMA은 지난 1년 동안 -15.5%를 기록한 ID 시장보다 더 좋은 성과를 냈습니다.주가 변동성Is SPMA's price volatile compared to industry and market?SPMA volatilitySPMA Average Weekly Movement4.5%Forestry Industry Average Movement6.1%Market Average Movement7.9%10% most volatile stocks in ID Market15.4%10% least volatile stocks in ID Market3.8%안정적인 주가: SPMA는 지난 3개월 동안 ID 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: SPMA의 주간 변동성(5%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트1976833Edward Sopananwww.ptsuparmatbk.com인도네시아에서 종이 및 관련 종이 제품을 제조 및 판매하는 회사입니다. 이 회사의 종이 제품에는 라미네이트 포장지와 갈색 크래프트, 백지, 샌드위치 리브 크래프트 재활용 종이, 카톤 종이 등이 있습니다. 또한 욕실, 미용, 냅킨 및 캐리어 티슈도 제공합니다.더 보기PT Suparma Tbk 기초 지표 요약Suparma의 순이익과 매출은 시가총액과 어떻게 비교됩니까?SPMA 기초 통계시가총액Rp820.06b순이익 (TTM)Rp103.29b매출 (TTM)Rp2.76t7.9x주가수익비율(P/E)0.3x주가매출비율(P/S)SPMA는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표SPMA 손익계산서 (TTM)매출Rp2.76t매출원가Rp2.34t총이익Rp416.03b기타 비용Rp312.75b순이익Rp103.29b최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)25.19총이익률15.09%순이익률3.75%부채/자본 비율26.0%SPMA의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 09:00종가2026/05/20 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스PT Suparma Tbk는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).
Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: Rp20.18 (vs Rp7.72 in 3Q 2023)Third quarter 2024 results: EPS: Rp20.18 (up from Rp7.72 in 3Q 2023). Revenue: Rp686.1b (up 5.5% from 3Q 2023). Net income: Rp65.9b (up 171% from 3Q 2023). Profit margin: 9.6% (up from 3.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Reported Earnings • May 01First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025)First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 01Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024)Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m).
Board Change • Oct 24Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • May 05PT Suparma Tbk, Annual General Meeting, Jun 10, 2025PT Suparma Tbk, Annual General Meeting, Jun 10, 2025.
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: Rp20.18 (vs Rp7.72 in 3Q 2023)Third quarter 2024 results: EPS: Rp20.18 (up from Rp7.72 in 3Q 2023). Revenue: Rp686.1b (up 5.5% from 3Q 2023). Net income: Rp65.9b (up 171% from 3Q 2023). Profit margin: 9.6% (up from 3.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Reported Earnings • Jul 31Second quarter 2024 earnings released: EPS: Rp8.89 (vs Rp12.20 in 2Q 2023)Second quarter 2024 results: EPS: Rp8.89 (down from Rp12.20 in 2Q 2023). Revenue: Rp618.2b (up 2.5% from 2Q 2023). Net income: Rp26.4b (down 31% from 2Q 2023). Profit margin: 4.3% (down from 6.4% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
New Risk • Jul 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.6% net profit margin). Market cap is less than US$100m (Rp908.4b market cap, or US$55.4m).
공시 • May 09PT Suparma Tbk, Annual General Meeting, Jun 14, 2024PT Suparma Tbk, Annual General Meeting, Jun 14, 2024. Location: Vasa Hotel Surabaya Jawa Timur Indonesia
Reported Earnings • May 04First quarter 2024 earnings released: EPS: Rp7.00 (vs Rp25.65 in 1Q 2023)First quarter 2024 results: EPS: Rp7.00 (down from Rp25.65 in 1Q 2023). Revenue: Rp657.6b (down 5.9% from 1Q 2023). Net income: Rp22.6b (down 72% from 1Q 2023). Profit margin: 3.4% (down from 12% in 1Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 7% per year.
New Risk • Apr 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.7% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.7% net profit margin). Market cap is less than US$100m (Rp1.09t market cap, or US$68.4m).
Reported Earnings • Apr 03Full year 2023 earnings released: EPS: Rp57.00 (vs Rp107 in FY 2022)Full year 2023 results: EPS: Rp57.00 (down from Rp107 in FY 2022). Revenue: Rp2.66t (down 15% from FY 2022). Net income: Rp178.7b (down 47% from FY 2022). Profit margin: 6.7% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year.
Valuation Update With 7 Day Price Move • Oct 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to Rp338, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 4x in the Forestry industry in Indonesia. Total returns to shareholders of 85% over the past three years.
Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: Rp12.30 (vs Rp10.32 in 2Q 2022)Second quarter 2023 results: EPS: Rp12.30 (up from Rp10.32 in 2Q 2022). Revenue: Rp603.0b (down 23% from 2Q 2022). Net income: Rp38.5b (up 4.8% from 2Q 2022). Profit margin: 6.4% (up from 4.7% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth.
공시 • May 19PT Suparma Tbk, Annual General Meeting, Jun 08, 2023PT Suparma Tbk, Annual General Meeting, Jun 08, 2023, at 03:00 Coordinated Universal Time. Location: Meeting Room of PT Suparma Tbk Jl. Mastrip No. 856 Surabaya Indonesia Agenda: To consider the approval on the company's annual report including the company's audited financial statements and the board of commissioners' Supervisory Duty Report for financial year ended on December 31, 2022; to consider to determine the use of the company's net profit for the financial year ended on December 31, 2022; to consider to appoint the Registered Public Accountant and/or Registered Public Accounting Firm that will Audit the company's financial statements for the financial year ended on December 31, 2023; and to transact such other business issues.
Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Corporate Secretary & Independent Director Hendro Luhur is the most experienced director on the board, commencing their role in 1998. Independent Commissioner M. Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Nov 06Third quarter 2022 earnings released: EPS: Rp54.76 (vs Rp72.09 in 3Q 2021)Third quarter 2022 results: EPS: Rp54.76. Revenue: Rp814.9b (up 15% from 3Q 2021). Net income: Rp130.9b (up 12% from 3Q 2021). Profit margin: 16% (in line with 3Q 2021).
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improved over the past weekAfter last week's 27% share price gain to Rp555, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 15x in the Forestry industry in Indonesia. Total returns to shareholders of 145% over the past three years.
Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp755, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 19x in the Forestry industry in Indonesia. Total returns to shareholders of 266% over the past three years.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Commissioner Tan Juanto was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp815, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 325% over the past three years.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp685, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 247% over the past three years.
Valuation Update With 7 Day Price Move • Nov 24Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp585, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 213% over the past three years.
Reported Earnings • Nov 07Third quarter 2021 earnings released: EPS Rp79.47 (vs Rp7.85 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp710.0b (up 30% from 3Q 2020). Net income: Rp117.1b (up 435% from 3Q 2020). Profit margin: 17% (up from 4.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Nov 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to Rp422, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 131% over the past three years.
Reported Earnings • Jul 30Second quarter 2021 earnings released: EPS Rp24.89 (vs Rp30.91 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: Rp616.9b (up 43% from 2Q 2020). Net income: Rp37.7b (down 56% from 2Q 2020). Profit margin: 6.1% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 27% per year.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 19% share price gain to Rp390, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 112% over the past three years.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp610, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 123% over the past three years.
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to Rp520, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 12x in the Forestry industry in Indonesia. Total returns to shareholders of 82% over the past three years.
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp370, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 24% over the past three years.
Is New 90 Day High Low • Feb 26New 90-day high: Rp336The company is up 3.0% from its price of Rp326 on 27 November 2020. The Indonesian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 62% over the same period.
Is New 90 Day High Low • Jan 28New 90-day low: Rp276The company is down 1.0% from its price of Rp280 on 27 October 2020. The Indonesian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 61% over the same period.
Is New 90 Day High Low • Nov 11New 90-day high: Rp296The company is up 15% from its price of Rp258 on 13 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 1.0% over the same period.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of Rp118.1b, down 19% from the prior year. Total revenue was Rp2.18t over the last 12 months, down 15% from the prior year.
